Project

A phase III trial of marizomib in combination with standard

Automatically Closed ยท 2018 until 2021

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2018
End Date
2021
Financing
Industry
Study Design
Phase III Studie
Keywords
Marizomib, Glioblastoma, Phase III, EORTC
Homepage
Partner
EORTC
Brief description/objective

Marizomib in Glioblastoma